Olink Holding AB Company Overview
About Olink Holding AB
Olink Holding (NASDAQ:OLK) specializes in proteomics technology, pioneering precision protein biomarker solutions. These innovative tools and services are designed to drive groundbreaking discovery in various scientific fields, notably within the pharmaceutical and biotechnology sectors. Olink's mission revolves around enhancing the understanding of diseases and biological processes, thereby accelerating the development of novel diagnostics and therapeutics. The company's projects span multiple disciplines, with a significant focus on collaborations and partnerships aimed at advancing personalized medicine and improving patient outcomes. Through its comprehensive protein biomarker platform, Olink supports researchers and healthcare professionals worldwide, endeavoring to unlock new insights into health and disease at the molecular level.
Snapshot
Operations
Produtos e/ou serviços de Olink Holding AB
- Proteomics solutions for biomarker discovery utilizing next-generation technology to accelerate precision medicine.
- Olink Explore for high-multiplex protein biomarker analysis, using a unique proximity extension assay technology.
- Olink Target 96 for focused protein biomarker studies, offering high specificity and sensitivity.
- Olink Focus panels, designed for specific research areas including oncology and cardiovascular diseases.
- Biomarker services, providing comprehensive support from study design to data analysis and insights.
- Custom assay development services, enabling tailored solutions for unique research needs.
equipe executiva do Olink Holding AB
- Mr. Jon HeimerCEO & Director
- Mr. Carl RaimondInterim Chief Commercial Officer & President
- Mr. Oskar HjelmChief Financial Officer
- Ms. Anna MarsellChief Operating Officer
- Ms. Linda Ramirez-Eaves Esq.General Counsel
- Andrea PranderCorporate Communications Manager
- Mr. Elias BerglundChief People Officer
- Mr. Rickard El TarziChief Strategy & Product Officer
- Ms. Maria Liminga BjorkChief Research & Development Officer
- Stina ThormanInvestor Relations Officer